The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Private investments for a major institutional investor
Represented a major institutional investor in connection with over 30 investments, with an aggregate value of nearly $3 billion, in various private more
Litigated consumer credit and credit rating dispute on behalf of a global leader in information solutions
Representing a global leader in information solutions in numerous individual and class actions arising out of consumer credit and credit rating more
Acquisition of marine cargo handling company
Represented a global market-leading company in its acquisition of Swedish group (bulk handling systems for terminal and self-unloading ship more
Financial services for a stock transfer business agency
Represented a large New York-based national independent stock transfer agency in establishing successor borrower programs in connection with more